Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (381-390 of 775) with videos related to

Pageof 78
Sort By:
Hepatology (Baltimore, Md.)|October 19, 2011
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ outputAnna Baghdasaryan, Thierry Claudel, Judith Gumhold, et al.
European Journal of Gastroenterology & Hepatology|December 7, 2016
The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control studyLukas W Unger, Merima Herac, Katharina Staufer, et al.
Endoscopy|November 21, 2014
High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or settingKarin Kozbial, Karoline Reinhart, Georg Heinze, et al.
United European Gastroenterology Journal|December 15, 2017
The role of TIPS in the management of liver transplant candidatesLukas W Unger, Theresa Stork, Theresa Bucsics, et al.
Investigative Radiology|June 17, 2017
Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic ImplicationsUlrika Asenbaum, Ahmed Ba-Ssalamah, Mattias Mandorfer, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
Lactate Improves Prediction of Short-Term Mortality in Critically Ill Patients With Cirrhosis: A Multinational StudyAndreas Drolz, Thomas Horvatits, Karoline Rutter, et al.
Journal of Hepatology|September 6, 2016
Metabolic preconditioning protects BSEP/ABCB11<sup>-/-</sup> mice against cholestatic liver injuryClaudia D Fuchs, Gustav Paumgartner, Annika Wahlström, et al.
Gastroenterology|November 8, 2011
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasisSalvatore Modica, Michele Petruzzelli, Elena Bellafante, et al.
Journal of Hepatology|January 25, 2015
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesityMichaela Mueller, Anders Thorell, Thierry Claudel, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Pageof 78

Showing results (381-390 of 775) with videos related to

Sort By:
Pageof 78
Hepatology (Baltimore, Md.)|October 19, 2011
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ outputAnna Baghdasaryan, Thierry Claudel, Judith Gumhold, et al.
European Journal of Gastroenterology & Hepatology|December 7, 2016
The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control studyLukas W Unger, Merima Herac, Katharina Staufer, et al.
Endoscopy|November 21, 2014
High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or settingKarin Kozbial, Karoline Reinhart, Georg Heinze, et al.
United European Gastroenterology Journal|December 15, 2017
The role of TIPS in the management of liver transplant candidatesLukas W Unger, Theresa Stork, Theresa Bucsics, et al.
Investigative Radiology|June 17, 2017
Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic ImplicationsUlrika Asenbaum, Ahmed Ba-Ssalamah, Mattias Mandorfer, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
Lactate Improves Prediction of Short-Term Mortality in Critically Ill Patients With Cirrhosis: A Multinational StudyAndreas Drolz, Thomas Horvatits, Karoline Rutter, et al.
Journal of Hepatology|September 6, 2016
Metabolic preconditioning protects BSEP/ABCB11<sup>-/-</sup> mice against cholestatic liver injuryClaudia D Fuchs, Gustav Paumgartner, Annika Wahlström, et al.
Gastroenterology|November 8, 2011
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasisSalvatore Modica, Michele Petruzzelli, Elena Bellafante, et al.
Journal of Hepatology|January 25, 2015
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesityMichaela Mueller, Anders Thorell, Thierry Claudel, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Pageof 78